T3	Subject 37 76	in patients with thalassemia intermedia
T4	Treatment 17 36	low-dose HU therapy
T6	Effect 81 105	increase total Hb levels
T7	Treat-Disorder 54 76	thalassemia intermedia
T8	Drug 26 28	HU
T9	Dosage 17 25	low-dose
T10	Speculation_cue 77 80	may
T5	Potential_therapeutic_event 29 36	therapy
E1	Potential_therapeutic_event:T5 
